Medication-Assisted Treatment (MAT) Centers in Nebraska

mat is approved for opioid use disorder involving any opioid — heroin, fentanyl, prescription oxycodone, hydrocodone, or morphine. Nebraska clinicians treat patients whose OUD started with a pain prescription just as readily as those using illicit opioids.

Common extra charges include urine drug-screen add-ons ($10–$50), missed-appointment fees, and pharmacy dispensing fees for take-home methadone doses. Always ask for a written fee schedule before your first visit at any Nebraska provider.

Yes. Nebraska Medicaid (Heritage Health) covers FDA-approved medications for opioid use disorder, including mat, plus the associated counseling, drug testing, and clinic visits. Specific formulary details (preferred agents, long-acting injectables) vary by plan — check with your Nebraska Medicaid (Heritage Health) managed-care organization.

Yes. HSA and FSA funds are eligible for all MAT out-of-pocket expenses — copays, medication, counseling, lab tests — because MAT is IRS-qualified medical care. Keep itemized receipts from MAT programs for tax records.

Clinics maintain a confidential medical record covering diagnosis, treatment plan, drug screens, counseling notes, and dose history. Records are protected by 42 CFR Part 2 — stricter than HIPAA — and cannot be released without your written consent or a specific court order.

Typically no — Nebraska family and criminal courts increasingly recognize MAT as standard medical care. Longer continuous treatment is often viewed favorably by courts as evidence of stability. Share treatment documentation with your attorney for court proceedings.

Bring a photo ID, insurance or Nebraska Medicaid (Heritage Health) card (if applicable), and a list of current medications. Proof of address and pharmacy information speed up buprenorphine prescribing. Intake staff will walk you through paperwork at your first visit.

A positive urine drug screen is expected for most patients entering MAT — it confirms the diagnosis. Positive screens are not used to deny admission at any Nebraska SAMHSA-certified OTP. Your clinician interprets results and builds an individualized plan from there.

Buprenorphine and methadone do not test positive on standard 5-panel drug tests — specialty panels are needed. Naltrexone and its metabolites are not screened on standard panels. Share an MAT provider letter with any employer or court drug-testing program to avoid confusion.

No — abrupt discontinuation is dangerous for the pregnancy. Call your Nebraska MAT clinic right away; the team will coordinate with obstetrics to continue medication safely and arrange any dose adjustments needed as the pregnancy progresses.

Peer-recovery support workers are trained individuals with lived recovery experience who provide mentoring, accompaniment to appointments, and navigation of resources. Nebraska Medicaid reimburses peer-support services; most mid-sized MAT programs employ certified peer specialists.

Only if you disclose it. Your Nebraska clinic cannot inform your employer under 42 CFR Part 2. If you need FMLA leave, HR can verify the medical appointment without learning the diagnosis. Safety-sensitive roles may have specific DOT rules — consult an employment attorney.